Advancing Eczema Management

Eczema, particularly atopic dermatitis, affects millions of individuals worldwide, with a significant portion experiencing moderate to severe symptoms that profoundly impact their quality of life. Managing eczema involves a range of treatments, from emollients to potent systemic therapies. However, for patients with severe forms of eczema who do not respond adequately to traditional treatments, biologic therapies have emerged as a groundbreaking alternative.

In this conversation with Amena Warner, Head of Clinical Services for Allergy UK, Professor Carsten Flohr, a leading consultant dermatologist and expert in atopic eczema, offers his insights into the evolving role of biologics in treating severe eczema. He discusses the criteria for patient suitability, the patient pathway, and key considerations for healthcare professionals managing these treatments. This conversation is particularly relevant for GPs and nurses, who play a crucial role in the multidisciplinary care of eczema patients.